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ABSTRACT

The negative correlation between olfactory sensitivity and depression has been well
documented, but the biological processes underpinning the relationship are not understood. This
study explored a potential relationship between olfactory sensitivity, stress, and resilience to
stress, specifically examining neuropeptide y (NPY) as a mediator. In phase I, 197 UTC students
participated in a survey measuring stress and resilience among other factors. Of this sample, 25
students volunteered for phase II, in which they took an olfactory threshold test and gave blood.
Serum levels of cortisol and NPY were analyzed from blood samples. Correlational analyses
suggest a positive effect of stress (p=.013) and a negative effect of resilience (p=.003) on
olfactory thresholds, while biological markers were inconclusive. Future studies should
incorporate the diagnosis of stress disorders, as biological markers may not significantly
fluctuate based on non-clinical levels of stress.
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CHAPTER I
INTRODUCTION

Olfaction is an integral part of daily life. As one of the primary senses, it defines a great
deal of human experience. Olfaction plays a role in many everyday situations: deciding what to
eat (Kremer, Holthuysen, & Boesveldt, 2014), recalling autobiographical memories (Willander
& Larsson, 2007), and even selecting a mate (Sergeant, Davies, Dickins, & Griffiths, 2005). In
addition, olfactory research is also revealing relationships between the sense of smell and many
aspects of psychology: memory, mood, and mental health to name a few (Weir, 2011). In order
to engage in the study of olfaction and its effects, it is important to be able to measure it in a
meaningful way.

Types of Measurement
Olfactory function varies in a number of aspects, and each one is important in measuring
overall olfactory performance. (Lotsch, Reichmann, & Hummel, 2008). First of all, smell ability
can be measured through odor thresholds. An odor threshold is calculated by offering a range of
odorant concentrations to determine how sensitive the individual is to the odorant (C. U. M.
Smith, 2008); the calculated value represents the concentration at which the person would
theoretically smell the odorant half of the time. This is an important point of distinction: any
concentration above this point is more likely to be smelled than not, and anything lower is more
likely to not be smelled. Olfaction is also measured in regard to smell identification. This relies
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on the participant to smell a given odorant and name it (Doty, Shaman, Kimmelman, & Dann,
1984). Other tests measure the ability to discriminate between different odors (Choudhury,
Moberg, & Doty, 2003), as well as how people rate qualitative aspects of a given smell (Zarzo,
2011). As previously mentioned, each of these methods of olfactory analysis is useful for
evaluating performance.

Olfactory Sensitivity and Depression
Researchers studying depression and olfaction have already utilized many of these
analysis principles. In a study of women who sought in-patient treatment for depression, the
patient group displayed a decreased ability to discriminate between odors as compared to a
control group (Croy et al., 2014). As mood improved over the course of treatment, however, so
did olfactory ability; there was no significant difference between groups in regard to odor
discrimination once treatment was finished. Additionally, depression has been shown to have an
effect on olfactory threshold. Individuals with severe depression display an increased odor
threshold for multiple odorants in comparison to healthy controls (Lombion-Pouthier, Vandel,
Nezelof, Haffen, & Millot, 2006). The researchers also found that the depressed group over-rated
the quality of pleasant odorants (for example violet, orange, and cinnamon), finding them more
pleasurable overall than the healthy group. Further studies have revealed more about this
discrepancy in perceived smell quality for depressed individuals; Atanasova et al. (2010) found
that unpleasant smells are rated as more unpleasant by patients with depression. Together with
the previous finding, this suggests that depression causes a polarity in smell perception rather
than causing all odors to shift in one direction (pleasant or unpleasant). Finally, Atanasova et al.
(2010) also discovered a difference in intensity between good and bad odors. Depressed patients
2

reported a universally foul smell (butyric acid) as being much stronger than the universally
pleasant smell (vanilla), even at odorant levels that healthy controls reported no difference in
intensity. The combination of available data has led some researchers to conclude that olfaction
is a reliable marker for depression (Croy et al., 2014).

Olfactory Sensitivity and Stress
The relationship between depression and olfaction has been substantially explored; stress,
on the other hand, has not. The American Psychological Association (2014) reported that, for
2014, the top two causes of stress in the United States were job pressure and money. Seventyseven percent of Americans report regular physical symptoms of stress, and 73% experience
psychological symptoms. According to a joint poll by MtvU and the Associated Press (2009),
60% of college students have been so stressed that it impacted their work, and close to the same
amount (53%) were too stressed to engage in social activity. Additionally, stress may be a
correlate of collegiate obesity (Odlaug et al., 2015) and consideration of suicide (S. S. Smith et
al., 2015) It is clear, therefore, that stress is a major issue facing college students.
Similar to depression, stress has been implicated in affecting olfaction through the quality
of smells. Krusemark, Novak, Gitelman, and Li (2013) found that when participants were
induced with anxiety by viewing unsettling pictures they reported smells as more unpleasant and
responded stronger to these smells than when they were not anxious. Considering that anxiety
and stress responses share many of the same physical characteristics, this same effect of odor
unpleasantness could most likely result from stress as well. This assertion is supported by Croy,
Schellong, Joraschky, and Hummel (2010), who studied chemosensory event-related potentials
during olfactory processing in individuals with diagnosed PTSD. These individuals showed an
3

enhanced processing of unpleasant smells that correlated with the severity of their PTSD
symptoms, whereas there was no effect on the processing of pleasant smells. The authors did not,
however, find any meaningful difference in olfactory threshold levels between the PTSD and
healthy groups. In another study, researchers did observe an increase in sensitivity for scents
conditioned to be aversive (Ahs, Miller, Gordon, & Lundstrom, 2013). This could suggest a
decrease in threshold for smells associated with traumatic memories in PTSD patients. More
research is needed to determine whether olfactory sensitivity is indeed affected by levels of
stress.

Neurological Correlates of Stress and Olfaction
One strategy that may be employed to elucidate such effects is to examine the underlying
neural and hormonal processes of both stress and olfaction. One of the primary components of
the body’s stress system is the hypothalamic-pituitary-adrenal axis (HPA), which mediates the
response to physical and emotional stressors (Tsigos & Chrousos, 2002). Upon exposure to stress
the hypothalamus sends corticotropin-releasing factor (CRF) to the pituitary gland, causing it to
release adrenocorticotropic hormone. This hormone in turn activates the adrenal cortex, leading
to the production of cortisol. Serum cortisol is frequently used to measure stress levels, as it
correlates strongly with the amount of experienced stress (Oswald et al., 2006).
Olfaction has also been shown to affect the activity of the glands involved with the HPA.
For example, the smell of compounds similar to sex hormones has been tied to certain
hypothalamic activities (Savic, Berglund, Gulyas, & Per, 2001). Specifically, researchers found
that the hypothalamus of each male participant was activated upon the olfactory uptake of an
estrogen-like compound. Females had similar results when smelling compounds similar to male
4

androgens. Both of these compounds comprise steroid formations, making them structurally
similar to cortisol. Another piece of the HPA stress pathway, the pituitary gland, has also been
tied to olfaction. A commonly reported side-effect of pituitary surgery is anosmia, or the loss of
the ability to smell; however, this link is not currently well-understood (Tam, Duggal, &
Rotenberg, 2013).

Resilience and Neuropeptide Y
Olfaction and stress share aspects of their neural pathway. Resilience does as well as an
agent of stress reduction. Resilience is the ability to deal with stressors in a way that enables the
individual to minimize the negative consequences of the stress itself (American Psychological
Association, 2016). This trait is often ascribed to people who persevere after a traumatic
experience rather than succumbing to their stress (Iacoviello & Charney, 2016). This has led
researchers to explore resilience as a potential preventative measure against traumatic stress in
populations at risk for trauma, such as soldiers in foreign wars (Cacioppo et al., 2015). It is also
being sought as a treatment for trauma that has already taken place, as learning to be resilient
may counteract the stress response in PTSD. (Burton, Cooper, Feeny, & Zoellner, 2015).
Resilience is defined in terms of both behavioral and physiological adaptations to
stressful events (Feder, Nestler, & Charney, 2009). Individuals who express behavioral resilience
are those who engage in activities and thought practices that promote characteristics indicative of
mental well-being. A few examples of these traits are adaptiveness, self-esteem, and strength in
social structure (Connor & Davidson, 2003). People who express an increased tendency towards
these types of behaviors regularly score lower on measures of stress and depression. These
psychological aspects accompany a corresponding biological response in the activity of
5

neuropeptide y (NPY) (Sadjyk, Fitz, & Shekhar, 2006). By counteracting the effects of CRF in
the amygdala, NPY serves to reduce the magnitude and longevity of the stress response.
NPY has been shown to correlate closely with resilience and against stress through its
behavior in the HPA (Reichmann & Holzer, 2016). One of the primary roles of NPY is the
control of body weight and metabolism, which is achieved through its activity in the
hypothalamus following a meal (Nguyen, Herzog, & Sainsbury, 2011). Increased levels of NPY
in the paraventricular nucleus lead to an increased hunger response (Hanson & Dallman, 1995).
Additionally, giving nasal doses of NPY to rats before stress-inducing tasks reduced the stressrelated activation of the HPA axis (Sabban, Serova, Alaluf, Laukova, & Peddu, 2015). The link
between NPY and resilience suggests that, on a surface level, NPY would improve olfaction by
increasing stress resistance and thereby reducing the deleterious effects of stress on the sense of
smell.
A similar effect can be seen with NPY and resilience against depression. For example,
low NPY is very common among suicide attempters with depression. (Morales-Medina, Dumont,
& Quirion, 2010). After taking antidepressants, patients’ NPY levels increase as symptoms
improve. Additionally, Morales-Medina et al. (2010) have indicated a genetic polymorphism Leu7Pro - that leads to enhanced production and faster processing of NPY. Individuals with this
mutation have exhibited evidence of depression resistance compared to those with the normal
gene. The potential mechanism of NPY’s effects on stress may be tied to the amygdala. PTSD is
tied to amygdalar dysfunction, and NPY has been shown to be a marker for resilience in combat
veterans (Yehuda, Brand, & Yang, 2006); soldiers with combat exposure but without PTSD have
higher levels of NPY than those with PTSD, as well as veterans without combat exposure. When
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injected directly into the amygdala of rats, NPY leads to a reduction in stress-conditioned
behaviors (Flood, Baker, Hernandez, & Morley, 1989).
The amygdala has also been tied to olfactory function. People experience greater
amygdala activity as the foulness of presented odors increases (Zald & Pardo, 1997). Damage to
the amygdala results in significant impairment to odor memory and odor recognition (Buchanan,
Tranel, & Adolphs, 2003). Similar to NPY, olfactory ability has also been shown to correlate
negatively with depression (Croy et al., 2014) and PTSD (Croy et al., 2010); these effects on
smell can also be traced to activity between the olfactory sensory relay and the amygdala
(Krusemark et al., 2013). NPY may regulate this relationship as well. As found by Hansel,
Eipper, and Ronnett (2001), NPY works as a neuroproliferative factor. In one specific example,
it promotes the proliferation of olfactory neurons. NPY deficiencies in rats can cut the total
amount of these neurons in half. This is particularly interesting considering the nature of the
olfactory epithelium, as its neurons are being constantly renewed throughout adulthood (Yang,
He, & Hao, 2015). A decrease in neuroproliferation would not stop the death of these cells but
would certainly slow their regular replacement. This finding suggests that states coinciding with
low NPY over time, such as stress and depression, would lead to olfactory deficits via relative
reduction in olfactory neurons. In other words, NPY is tied to resilience against stress as well as
against olfactory dysfunction.

The Present Study
The current literature is suggestive of a link between stress, resilience, and olfactory
ability; however, this model has not been conclusively tested as a whole. Additionally, the
studies mentioned above focused on comparing healthy populations with those with clinical
7

diagnoses, but do not compare olfactory performance against psychological measures within
groups. These two issues comprise the focus of the current study.

Hypotheses
Psychological Correlations
1A) Stress, depression, and symptoms of traumatic experience will all correlate positively.
1B) Resilience will negatively correlate with stress, depression, and traumatic stress.

Physiological Correlations
2A) Serum NPY levels will correlate negatively with stress, depression and traumatic
experience, but positively with resilience.
2B) Olfactory sensitivity will also correlate negatively with stress, depression, and traumatic
experience, but positively with resilience.
2C) These correlations will be stronger for a bad smell than a good smell.
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CHAPTER II
METHOD

Review Board
The current study was approved by the Institutional Review Board of UTC (Appendix
A). As required by this approval, all electronic participant data has been stored in a manner
consistent with ensuring confidentiality. Physical copies of collected data have been placed in
locked storage and are inaccessible to individuals not involved in the current study.

Protection of Health Information
All investigators had current training as mandated by the Health Insurance Portability and
Accountability Act (HIPAA), the National Institutes of Health (NIH), and the Collaborative
Institutional Training Initiative (CITI) in regard to the handling of health information at the time
of their contributions to the current study.

Method Overview
The current study comprised two phases. The first consisted of several self-report
instruments to be described later in the method. This took place at the start of the spring 2016
semester at the University of Tennessee at Chattanooga (UTC). Subsequently, the second phase
required participants to come in person to Blood Assurance of Chattanooga to participate in an
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olfactory sensitivity test and give blood (Appendix B). Informed consent was obtained separately
for both phases (Appendix C and D).

Participants
For phase I, 197 participants were recruited among the student body. Students ranged in
age from 18 to 51 years old (M=20.9, SD=5.4), and females represented 81.7% of the sample. Of
these students, 25 agreed to participate in phase II of the study. This sample’s age range was 18
to 33 years old (M=22.7, SD=8.3) and comprised 19 women (76% of this sample). Self-report
demographic data for both phases are listed in tables 2.1 and 2.2.

Table 2.1 Age and Gender Demographics
Demographics
Gender (female)
Age (years)

Mean
Phase I Phase II
81.7%
76.0%
20.92
22.72

Std dev.
Phase I Phase II
--5.4
8.3

Table 2.2 Ethnicity Demographics
Demographics
White
Black
Hispanic
Asian
Other

Phase I
N
164
21
1
4
7

Percent
83.2%
10.7%
0.5%
2.0%
3.6%

10

N
21
2
0
0
2

Phase II
Percent
84.0%
8.0%
0.0%
0.0%
8.0%

In addition to general demographic information, participants answered a number of
questions regarding their personal health history. This primarily served to screen participants for
potential allergies to odorants, and it also enabled the investigation of how medical health might
relate to the variables listed in the hypotheses. Question topics included smoking habits, physical
injuries, illnesses, and allergies, among other medical issues. For a full listing of health data
surveyed, see figure 2.1.
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Health History
Thyroid
TBI
Stroke
Sinus Problems
Seasonal Allergy
Medical Allergy
Lung Disease
Kidney Disease
HIV
High BP
Hepatitis
Heart Disease
Headache
Gout
Food Allergy
Diabetes
Cancer
Broken Nose
Asthma
Anemia
0

20

40
Phase II

60
Phase I

Figure 2.1 Health History Data
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100
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Phase I Materials and Procedure
Perceived Stress Scale (PSS) (Appendix E)
Stress was measured using the Perceived Stress Scale (PSS) as developed by Cohen,
Kamarck, and Mermelstein (1983). This scale consists of 14 questions regarding how often
stressful and stress-related events have occurred within the past month. The focus is on the
feelings and perceptions of stress rather than counting up potentially stressful events. Participants
respond on a 0-4 scale with 0 meaning “never” and 4 meaning “very often.” In addressing net
stress over the course of an entire month, this scale can ideally assess cumulative everyday stress
over time rather than just a snapshot of the present moment.

Connor Davidson Resilience Scale (CD-RISC)
Resilience was measured by the Connor Davidson Resilience Scale (CD-RISC) (Connor
& Davidson, 2003). This scale comprises 25 items designed to address multiple facets of
psychological resilience, such as self-esteem, adaptability, and stability in relationships. The
calculation of trait subscores has not been validated, so only one overall resilience score is
measured. Each question gives respondents a 5-point response range, from 0 “not true at all” to 4
“true nearly all of the time.” A scale score was calculated for each participant by averaging the
numerical value of the items. Additional items were added to address two additional theoretical
factors of resilience: forgiveness and altruism. These items were included for the purpose of
future scale development, and were not factored into scale scores or otherwise considered in the
measurement of resilience for the current study.
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Center for Epidemiologic Studies Depression Scale Revised (CESD-R) (Appendix F)
Depression was be measured using the Center for Epidemiologic Studies Depression
Scale Revised (CESD-R) (Eaton, Smith, Ybarra, Muntaner, & Tien, 2004). The CESD-R is a 20item scale measuring nine aspects of depression. Responses are given by frequency of experience
on a 0-4 scale with 0 meaning “not at all or less than one day” and 4 meaning “nearly every day
for two weeks.” This scale is valuable in its ability to evaluate depression over a time frame
rather than in a single moment. The CESD-R is commonly used as a clinical tool for diagnosing
clinical depression, and has an established scoring system with this purpose in mind. The present
study, however, only requires a quantitation of depression among participants. Therefore, scores
were simply averaged into a scale score for each participant.

PTSD checklist for civilians (PCL-C) (Appendix G)
Participants also took the PTSD checklist for civilians (PCL-C) (Blanchard, JonesAlexander, Buckley, & Forneris, 1996). This survey consists of responses to stressful
experiences, and how often those responses have taken place in the last month. These questions
are answered on a 1-5 scale (1=Not at all, 5=Extremely). The questionnaire was designed to be a
self-report measure for use in clinical settings; the items are divided into categories based on
diagnostic criteria for PTSD from DSM-IV. Now that the DSM-5 has been released, these
criteria are no longer fully valid for diagnostic purposes. However, the scoring instructions also
allow for a total severity scale score comprising all items, which is all that is required for the
purposes of the current study. The PCL-C has been proven valid and reliable as a measure of
response to traumatic stress in general, which is not contingent on being aligned with the current
edition of the DSM.
14

Procedure
Participation in phase I was made available to students immediately upon IRB approval.
The demographic, health, and psychological surveys were hosted on Qualtrics and offered
through UTC’s research participation system website (SONA). Some surveys were also given in
person at the UTC University Center in order to incorporate students outside of the psychology
department. The entire survey took roughly 15 minutes to complete. Following the phase I
surveys, participants were emailed with information about the on-campus counseling center.
They were advised to seek aid there if they felt like they were having issues with stress,
depression, or traumatic stress. Additionally, they were provided with a brief description of
phase II and asked whether they were interested in participation. Each student who expressed
interest was contacted via email to set up an appointment for phase II.

Phase II Materials and Procedure
Wheeler-UTC Odor Threshold Test (WUTC)
Olfactory performance was assessed with an odor threshold test, as threshold tests
provide the greatest predictive value of overall performance among olfactory measures (Lotsch
et al., 2008). The Wheeler-UTC odor threshold test (WUTC) was designed to provide olfactory
threshold data on participants while also allowing researchers to measure response bias and task
performance (Tewalt, 2013). Five odorants (vanillin, p-cresol, pinene, ethanol, and isoamyl
acetate) were included in the original standardization of the WUTC. These were chosen based on
the variability of their chemical structures in order to assess multiple odorant-binding categories.
For the current study only two odorants were chosen in order to reduce administration
time: vanillin and p-cresol. While structurally similar, these odorants are perceived as qualitative
15

opposites by humans. Vanillin is almost universally regarded to have a good smell, theoretically
due to its presence in breast milk (Edraki et al., 2013). p-Cresol, on the other hand, is widely
regarded to be a foul odor. It is the primary compound associated with the scent of pig excrement
(Borrell, 2009), and is also present in human waste as well (Hamer, Preter, Windey, & Verbeke,
2011). Each compound comprises a hydroxyl group attached to an aromatic ring. p-Cresol also
possesses a methyl group para- to the hydroxyl group, whereas vanillin contains both an
aldehyde and an ether group. Finally, vanillin and p-cresol both have fairly small molecular
weights (152.15 and 108.13, respectively).
For each odorant, 20 concentrations were prepared. This was accomplished by first
mixing a concentrated stock standard in water. These concentrations were .08 mg/mL p-cresol
and .50 mg/mL vanillin. This constituted the most concentrated sample presented to participants;
the remaining 19 steps were created following a 1:3 dilution scheme. In the end, each successive
step had 1/3 the odorant concentration of the step that preceded it. Therefore, the lowest
concentration step for p-cresol was .07pg/mL and the lowest for vanillin was .43pg/mL. In
addition to the odorant-containing steps, 12 blanks were prepared that only included pure water.
Each presentation contained 10mL of solution, and was prepared in its own 20mL amber glass
vial and sealed with a screw-thread cap. Amber glass was chosen because vanillin is prone to
degradation from exposure to light. Overall the test contained 52 vials: 20 steps of vanillin, 20
steps of p-cresol, and 12 blanks.

Administration of the WUTC
Participants taking the WUTC sat down in a comfortable chair. They were informed that
a series of vials would be opened and presented to them, and they needed to smell the contents
16

and tell the researcher whether they smelled anything by answering “yes” or “no.” They were
also told that some vials would have a scent while others would not, and that they should give
the first response that occurs to them rather than trying to guess the correct answer. Finally, a
modification was made in the participant instructions of the WUTC: participants were given
specific instruction to consider the scent of water a lack of scent and given an example of a water
blank to smell. This modification was added to reduce potential positive response bias. Each vial
was then presented to the participant until they verbally responded to it, at which point the next
vial was given five seconds later. Responses were recorded by the researcher administering the
test and were hidden from the participant. Each vial was presented twice for a total of 104
presentations. The whole test was given in one of two randomized vial orders that alternated
between participants. Each order is characterized by which odorant’s highest concentration
appears first, in order to assess any effect it might have on smelling the other odorant. The test
was concluded once a reply had been given for each vial.

Blood Sampling
Upon completion of the WUTC, participants were directed to the certified phlebotomists
at Blood Assurance of Chattanooga for blood drawing. They were also given the option to donate
to Blood Assurance at the same time. Each participant gave roughly 10 mL of blood stored in
Vacutainer blood collection tubes, after which they received a $10 gift card. Each tube was
labelled with the date and time of the collection, as well as the participant number used to match
blood samples to phase I and WUTC data. Upon collection, samples were centrifuged at 2000 x
g for 10 minutes to separate the serum from the rest of the blood. The serum was then removed
and placed into a separate tube for storage. Centrifugation yielded 1-2 mL of serum from each
17

sample. Aprotonin was added to serum samples at 100µL per 1mL of serum to prevent protein
degradation through proteolysis. Serum and supernatant for each sample were then stored at a
maximum temperature of -20°C in a freezer in the UTC biochemistry lab. Once all blood
samples had been taken, each serum sample was thawed and an aliquot was taken from each for
further centrifugation. This time, samples underwent additional separation through the use of
30,000Da membrane filters. These samples were spun at 2000 x g for 30 minutes. Filtrate for
each sample was collected, labeled, and stored under refrigeration for the duration of the study.

Protein Analysis
After filtration, the presence and concentration of protein was measured for each sample
using the Bradford assay technique (Bradford, 1976). Five protein standards of known
concentration were prepared, and 100µL of each was mixed with 4mL of Bradford dye. This
solution was then vortexed and transferred to a plastic cuvette for analysis. The absorbance of
these solutions was determined with the protein analysis function of a Shimadzu Biospec-1601©.
The values obtained for each standard were used to calculate a standard curve that enables the
calculation of unknown protein concentrations in blood samples. Once the standards had been
analyzed, each sample was analyzed the same way after mixing 30µL of sample with 4mL of
Bradford dye.

UV/Fluorimeter
In order to quantify cortisol and NPY concentrations using advanced instrumentation, the
absorbance wavelength (λ) of each compound was ascertained. Molecular ring structures are
highly absorbent, and are typically representative of the absorbance of the molecule as a whole.
18

This applies to the steroid base of cortisol. Proteins can be much more complex due to the
variance of amino acids with ring structures that absorb at different wavelengths. Of these amino
acids, NPY contains only tyrosine. This erases the potentially increased difficulty inherent in
scanning UV absorbance in proteins. Standards for these compounds were analyzed using the
UV spectrometry function of a Shimadzu Biospec-1601© in order to determine those values.
Preparations of each standard were transferred to quartz cuvettes and scanned for UV
absorbance, indicated by a peak in the output of the instrument. This analysis yielded λ=252nm
for NPY and λ=290nm for cortisol.
Using the values from the UV scan, these wavelengths were refined using an Agilent
Cary Eclipse Fluorescence Spectrophotometer©. By scanning at a particular absorbance, the
excitation of the molecule can be determined. Scanning at this excitation will yield an
absorbance value, and continuing the process back and forth will eventually single out a specific
excitation wavelength. For NPY, this was 249nm and for cortisol this was 285nm. By recording
the peak size for numerous different standard concentrations, a standard curve was established
for both compounds. This enabled quantitation of both NPY and cortisol utilizing the
fluorimeter.

High Performance Liquid Chromatography (HPLC)
Standard solutions at known concentrations of each compound were prepared in order to
establish a standard curve using high performance liquid chromatography (HPLC). Each
standard was run through a Zorbax Poroshell© column, which separates compounds by
hydrophobicity. The UV detector of the HPLC was programmed to detect UV absorbance at the
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wavelengths determined from fluorimeter analysis. Instrument settings for the determination of
each compound are listed in Appendix H.
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CHAPTER III
RESULTS

Psychological Measures
For each measure given in the survey, a scale score was calculated by averaging the
individual scores of each item. Correlations were calculated between every pair of measures for
all 197 phase I participants. Among scores for the CESD-R, PSS, and PCL-C, all pairs exhibited
significant positive correlations (CESD-R/PSS: r = .641, p < .000; CESD-R/PCL-C: r = .779, p <
.000; PSS/PCL-C: r = .644, p < .000). Conversely, scale scores for the CD-RISC correlated
negatively with all three of the aforementioned measures (CESD-R: r = -.455, p < .000; PSS: r =
-.579, p < .000; PCL-C: r = -.360, p < .000).
Among the 25 phase II participants, all pairs of scores for the CESD-R, PSS, and PCL-C
yielded significant positive correlations (CESD-R/PSS: r = .751, p < .000; CESD-R/PCL-C: r =
.700, p < .000; PSS/PCL-C: r = .525, p = .007). As with the overall phase I scores, the CD-RISC
correlated negatively with the CESD-R and PSS within the phase II sample (CESD-R: r = -.636,
p = .001; PSS: r = -.644, p = .001). Unlike phase I, however, the correlation between CD-RISC
and PCL-C scale scores in phase II participants was not significant (r = -.258, p = .214). Finally,
from phase I to phase II there is a roughly one integer reduction in the maximum score attained
for the CESD-R, PSS, and PCL-C. An account of these scores can be found in Table 3.1. Using
regression analysis to account for all four psychological measures, stress was found to be a
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significant predictor of phase II participation (p = .05). This was an inverse relationship, wherein
lower stress increased the probably of volunteering for phase II.

Table 3.1 Psychological Measure Scale Scores
CESD-R
PSS
PCL-C
CD-RISC
Phase I Phase II Phase I Phase II Phase I Phase II Phase I Phase II
197
25
197
25
197
25
197
25
N
1.77
1.90
2.84
2.75
1.83
1.96
3.70
3.72
Mean
0.72
0.78
0.60
0.57
0.75
0.76
0.71
0.75
Std. Deviation
1.00
1.00
1.50
1.71
1.00
1.00
1.72
1.72
Minimum
4.75
3.70
4.64
3.86
4.59
3.35
5.00
4.88
Maximum
Descriptive
Statistics

Biological Measures
All 25 phase II samples were initially analyzed for protein concentration using protein
analysis. Protein was present in all samples (M = 39.5ug/mL, SD = 14ug/mL). NPY was
quantified using fluorimeter analysis; sample peak areas were converted to ug/mL using the
equation derived from the standard curve (M = 114.3ug/mL, SD = 36.18). A protein itself, NPY
nevertheless does not correlate with measured protein levels (r = .165, p = .429). Finally, the
concentration of cortisol in the samples was determined using HPLC. The relatively small
concentration of cortisol in the samples necessitated the use of an internal standard. Aliquots of
each sample were diluted with stock standard to reach an internal standard concentration of .6
ug/mL. The peak area of pure standard at this same concentration was subtracted from the peak
areas of the ensuing sample runs. The concentration in ug/mL was calculated from sample peak
areas using the equation of the standard curve (M = .093ug/mL, SD = .055ug/mL).
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Olfactory Thresholds
Olfactory thresholds were calculated using logistic regression to determine the
concentration at which each participant has an equal chance of smelling or not smelling the
odorant. Nagelkerke’s R2 values were calculated for each threshold. Similar to the r2 statistic
calculated for linear correlations, Nagelkerke’s R2 measures the goodness-of-fit of the data points
to a logistic regression (Peng, Lee, & Ingersoll, 2002). Thresholds with corresponding R2 values
less than .25 were discarded, as such a low score indicates that the data is a poor fit for
calculating logistic regressions. Five of the subjects’ vanillin thresholds and three of the subjects’
p-cresol thresholds were removed from further analysis for this reason.
An additional statistic was calculated to assess response bias. If a participant has a
tendency towards one answer over the other, it makes it more difficult to attribute results purely
to olfactory function. The statistic used to check this is B” (Stanislaw & Todorov, 1999).
Response bias is a function of two probabilities: how likely a participant is to answer yes when it
is correct to do so, and how likely that participant is to say yes when it is incorrect. A measure of
task performance was also calculated, called Youden’s J (Youden, 1950). This statistic measures
how “successful” a participant was at the threshold test by comparing the rate of correct yesses to
the rate of correct noes. A perfect J score would involve answering yes to every vial with
odorant, and no to every blank. In this sense it theoretically provides a different, less direct
assessment of olfactory performance. Threshold values for each odorant, accompanied by the
aforementioned statistics, can be found in Table 3.2.
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Table 3.2 Statistical Measures for Olfactory Threshold Test

Descriptive
Statistics
N
Mean
Std. Deviation
Minimum
Maximum

Threshold
Nag R2
B"
J
pppVanillin Cresol Vanillin Cresol Vanillin Cresol Vanillin
20
22
20
22
25
25
25
0.0228 0.0277
0.67
0.70
0.46
0.45
0.23
0.0379 0.0462
0.22
0.18
0.31
0.32
0.09
0.0002 0.0002
0.28
0.37
-0.19
-0.26
-0.08
0.1748 0.1983
1.00
1.00
0.86
0.87
0.39

pCresol
25
0.22
0.11
-0.10
0.40

The order of presentation was altered between administrations; 13 participants had order
A and 12 participants had order B. The vial order did not significantly affect threshold values for
vanillin (p = .134) or for p-cresol (p = .777). There was also no effect of order on participants’
combined B” (p = .563) or J (p = .109) scores.

Combined Results
Psychological Measures and Olfactory Thresholds
Correlations with vanillin were insignificant for all psychological measures. Thresholds
for p-cresol were positively correlated to PSS score, and negatively correlated to CD-RISC
score. Correlations for both odorants can be found in Table 3.3.

Table 3.3 Psychological Measures Correlated to Thresholds
Correlations
Vanillin
p-Cresol

CESD-R
PSS
PCL-C
CD-RISC
r
p
r
P
r
p
r
p
-0.157 0.507 -0.237 0.314 0.092 0.701 0.340 0.142
0.367 0.093 0.520 0.013 0.023 0.920 -0.600 0.003
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Regressions were also run to determine the combined ability of threshold, response bias,
and performance for each odorant in predicting scores on the psychological measures. When
accounting for the variability in all three, these analyses implicated the threshold of p-cresol to
be uniquely predictive of depression (p = .045), stress (p = .02), and resilience (p = .002). The
relationship was direct for depression and stress, and inverse for resilience. The response bias of
p-cresol was also uniquely predictive of depression (p = .021) and stress (p = .015) in an inverse
relationship. As opposed to p-cresol, the collection of olfactory measures revealed much less
when using vanillin. Only the response bias was predictive of any of the psychological measures,
and only for stress (p = .041, an inverse relationship).

Biological Measures and Olfactory Thresholds
Protein concentration did not significantly correlate with the thresholds for vanillin (r = .256, p = .275) or p-cresol (r = .134, p = .552). Similarly, NPY levels exhibited no significant
relationship with vanillin (r = -.137, p = .564) or p-cresol (r = .021, p = .927). Finally, neither
vanillin nor p-cresol correlated significantly with serum cortisol concentration (r = .024, p =
.919; r = .058, p = .796 respectively).

Psychological Measures and Biological Measures
The two measures of stress in the current study, PSS and cortisol, do not correlate with
one another (r = .063, p = .766). The measured concentration of the theoretical marker for
resilience against stress, NPY, correlates with neither resilience (r = -.118, p = .575) nor stress (r
= .218, p = .295). PCL-C score did correlate positively with protein levels (r = .447, p = .025).
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Relationships with Health Status
Upon analysis of data from the health questionnaire, a number of interesting relationships
were identified. Depression scores were positively correlated to lung disease (r = .154, p = .033),
which was also positively correlated with traumatic stress (r = .231, p = .001) and protein
concentration (r = .497, p = .011). Also of note, NPY concentration was positively correlated
with a history of traumatic brain injury (r = .537, p = .006). Three health issues that are typically
implicated in olfactory dysfunction (asthma, seasonal allergies, and sinus issues) were not
observed to share any significant relationships.
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CHAPTER IV
DISCUSSION

In the current study, stress was examined as a potential dampener of olfactory
performance. Resilience was measured as a counter-actor to the effects of stress: a trait beneficial
to the sense of smell. Depression was assessed in regard to olfactory performance as well, in
addition to traumatic stress. These psychological constructs were measured via survey.
Additionally, stress and resilience were measured biologically. This was accomplished by
determining concentrations of cortisol and NPY, respectively, in serum. This study constitutes
the first attempt to use resilience (via CD-RISC) and olfactory threshold data (via WUTC) to
clarify the relationship between olfactory sensitivity and stress. Ultimately, stress and resilience
are indeed correlated to olfactory performance; however, their respective biological markers
were inconclusive. A summary of the support for each stated hypothesis can be found in Table
4.1.
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Table 4.1 Hypothesis Support Summary
Hypotheses

1A

1B

2A

2B

2C

Supported?
Stress, depression, and traumatic stress
correlate positively
Strongly supported
Resilience correlates negatively with the above
three
Strongly supported
NPY will have a negative relationship with
stress, depression, and traumatic stress. It will
have a positive correlation with resilience
Inconclusive
Olfactory threshold will have correlations with
stress, depression, traumatic stress, and
resilience in the same pattern as expected for
NPY
Supported
Relationships will be stronger for the bad
smell, p-cresol
Supported

The relationships among stress, traumatic stress, depression, and resilience came out as
hypothesized in the full phase I sample. This was consistent with previous literature, and
indicated that the constructs involved are closely related; people who have high stress will tend
to be more depressed, and people who have high resilience will be resistant to both stress and
depression. The means and standard deviations of these measures were almost unchanged from
the 197 phase I participants to the 25 phase II participants. The ranges, however, got smaller in
phase II for the CESD-R, PSS, and PCL-C. This change took place specifically at the maximum
of these measures, where each phase II maximum was roughly one whole point less than its
phase I counterpart. Given that each was measured on a scale of 1-5, this is a considerably large
drop off. Ultimately, there was no representation within the phase II analyses of people who fall
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within the highest levels of stress, depression, and traumatic stress. As a clear illustration of this
effect, high stress was determined to be a significant predictor of nonparticipation in the second
phase. It may be necessary to restrict future studies to one phase in order to prevent this effect.
Among the psychological scales that were measured, stress and resilience did have
significant relationships with the olfactory threshold for p-cresol. This was not the case with
vanillin. Additionally, the combination of threshold, response bias, and task performance was
much more predictive of psychological measures when using p-cresol instead of vanillin. This
may suggest that foul smells are more vulnerable to the effects of stress-related loss of olfactory
sensitivity than other smells, possibly due to an unconscious aversion to further negative stimuli
in a highly stressed state. Furthermore, the good smell of vanillin may be particularly robust
against alterations. Vanillin is present in human breast milk and amniotic fluid (Edraki et al.,
2013), so its detection may be prioritized through natural selection. Additionally, the observed
outcome may be attributed to the relationship of each odorant to olfactory-binding proteins
(OBPs). These proteins reside within the mucus membrane of the nasal cavity and aid in the
transport of odorant molecules to the olfactory bulb (Goldberg, Turpin, & Price, 1979). Previous
studies on bovine OBPs indicate that vanillin does not bind with them (Pevsner, Hou, Snowman,
& Snyder, 1990), while p-cresol does quite strongly (Karthikeyan et al., 2014). This suggests that
the effects of stress and resilience may specifically affect OBP function. As a result, olfactory
performance for odorants that rely on OBPs for uptake into the olfactory epithelium could be
much more vulnerable to stress than for those that do not. This ultimately suggests that odor
selection is vastly important when assessing olfactory function; the use of a single odorant
cannot represent olfactory performance as a whole.
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Biological compounds measured in blood serum samples consisted of cortisol and NPY,
as well as the level of overall protein present. NPY, a protein itself, did not correlate with the
total protein concentration. This was due most likely to the multitude of other proteins present in
human blood; at least 325 different proteins have been identified in the serum portion alone
(Pieper et al., 2003). Therefore, the variance in NPY does not have enough influence to
noticeably alter the overall concentration of serum protein. Additionally, there is no observed
relationship between NPY and cortisol. As the biological indicators of resilience and stress
(respectively), they should theoretically share an inverse relationship as opposed forces. The fact
that they do not suggests that there is a more complicated set of circumstances governing their
concentrations. In its role as a hunger regulator, NPY may fluctuate based on an individual’s
satiety at a given time (Kalra, Dube, Sahu, Phelps, & Kalra, 1991). This is compounded by the
fact that cortisol drops considerably over the course of the day (Wust et al., 2000).
Further still, these two compounds were not found to correlate with their corresponding
psychological measures. This may be a result of the nature of the scales; both the PSS and the
CD-RISC ask participants to indicate how well the statements have applied to them in the past
month. On the other hand, NPY and cortisol measured in the blood are emblematic of the state of
the body at the exact time the blood was drawn. Momentary stress, such as that associated with
phlebotomy needles, may have a disproportionately large effect on the levels of these
compounds. It is possible that biological markers are not good indicators of long-term
physiological trends, but this would run contrary to the aforementioned literature on stress and
resilience. It is more likely that this observed result is another consequence of the reduced range
in phase II participants’ psychological scale scores. Long-term stress may not have a noticeable
effect on the normal variability of cortisol concentration unless that stress is very high. Likewise,
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individuals with normal levels of stress may not exhibit NPY levels according to their
psychological resilience; NPY levels are highest after exhibiting resilience against a recognized
stressor (Yehuda et al., 2006). Ultimately, this incongruence between psychological and
biological measures suggests that olfactory dysfunction at the hands of stress is accumulated
over time rather than being subject to acute loss.
This conclusion lends credence to the proposed mechanism of loss of olfactory
sensitivity. Stress-related olfactory loss was theorized to arise out of a gradual reduction in
olfactory neurons. This reduction was assumed to occur not from excess neuronal destruction,
but rather from a lack of neuroproliferation. Since the replenishment of the olfactory bulb is so
rapid, interrupting the creation of new neurons could significantly deplete the population of
neurons in a matter of weeks. Despite the fact that NPY did not share a relationship with
olfactory function in this study, it is not unreasonable to suggest that the NPY level on the day of
blood collection may not be indicative of the overall trend in NPY over a period of time when
stress is high.
Additional relationships were discovered through the analysis of health information.
Most notable among these is the correlation between NPY and traumatic brain injury. As
previously mentioned, the rise in NPY corresponding with resilience is contingent upon needing
to utilize that trait. Physical trauma is capable of creating psychological trauma (deRoon-Cassini,
Mancini, Rusch, & Bonanno, 2010), therefore a traumatic brain injury could trigger the need for
psychological resilience. Also of note is the relationship between lung disease and traumatic
stress. This makes sense, as individuals diagnosed with PTSD have a greater lifetime prevalence
of many types of disease (Weisberg et al., 2002), including lung disease. This does not explain,
however, why the many other diseases on the health questionnaire did not also correlate with
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traumatic stress. Smoking may be another culprit here. Although smoking history did not
correlate with lung disease in the present data, it did correlate with stress. When considering this,
it is important to point out that a large majority of the participants were between the ages of 1822. Many of the diseases listed in the survey do not arise for most people until later in life, such
as high blood pressure, stroke, and heart disease. Finally, it is also interesting that olfactory
function was not affected by asthma, seasonal allergies, or sinus problems. All three of these
health issues were widely represented in the phase II sample. It may be that these illnesses all
have acute effects on olfactory ability. The questions on the survey simply ask for a history, so
they are not necessarily representative of the current health state as it would apply to olfactory
performance.
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CHAPTER V
CONCLUSION

The evidence gathered in the current study suggests that, in the end, stress leads to and
resilience protects from the loss of olfactory ability. However, without the confirmation of their
biological correlates (cortisol and NPY, respectively) it is impossible to determine whether each
factor is acting independently or if they are simply opposite ends of the same process.

Limitations
One primary limitation of the present study was the number of participants in phase II.
With only 25 individuals, there was not enough statistical power to ensure that all existing
relationships were identified. This also means the effects that were found to be significant were
more vulnerable to the skewing nature of extreme values. With a larger number of subjects there
would be more certainty with regard to the accuracy of the given results. Additionally, the small
sample did not include any individuals who scored in the highest quarter of the CESD-R, PSS, or
PCL-C. This limits the generalizability of the present findings, as it fails to account for people
with extreme levels of stress and depression. Finally, the overabundance of females as opposed
to males may have affected the results. Women have lower olfactory thresholds than men on
average (Diamond, Dalton, Doolittle, & Breslin, 2005). The hormonal fluctuations brought on by
the menstrual cycle also alter olfactory performance (LeMay, 2014). Participants were not asked
about their menstrual cycle though, so any variability resulting from it is unaccounted for.
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There were a number of limitations with the measurement of NPY and cortisol as well.
The ideal method for analyzing levels of NPY is by radioimmunoassay. This lies outside the
possibilities of the UTC biochemistry lab, so the concentration of serum NPY was quantified
using a fluorimeter. This instrument reads the amount of UV absorbance of each sample for a
given wavelength. This is the limit of specificity for the fluorimeter; any proteins or other
compounds that absorb at the set wavelength will add to the measured absorbance. Therefore, the
calculated values for NPY are vulnerable to overstating the amount of NPY actually present.
Also, there are a number of factors contributing to the variability of cortisol and NPY that were
not controlled for. For example, cortisol levels undergo a sharp increase after waking up in
roughly 75% of individuals (Wust et al., 2000). NPY levels fluctuate based on hunger (Kalra et
al., 1991). To properly account for these effects, participants would need to submit to strict
dietary instructions and multiple blood draws at different times of day.
Another limiting factor was the utilization of only one type of smell test. While threshold
is the most telling measurement, smell identification and discrimination also make up a sizeable
portion of overall olfactory performance (Lotsch et al., 2008). Not only could these measures
help form a more comprehensive picture of each participant’s ability to smell, but they could also
help to reveal odor-specific and test-specific olfactory relationships similar to those suggested in
the present study. The threshold test is also limited itself in that 10% of scores had to be
discarded due to a lack of fit with the logistic regression analysis (as measured by Nagelkerke’s
R2). While this is beneficial for ensuring the accuracy of relationships between threshold and
other variables, it exacerbates the issue of having a small sample size. Having additional
measures of olfactory performance could help alleviate this problem. Finally, stress may affect
olfactory threshold measurements in unexpected ways. Response bias was predictive of stress
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with both odorants; people with higher stress were more likely to answer “no” to any given
odorant presentation. This suggests that highly stressed individuals could have a predilection
towards not being wrong, viewing “no” as the safer choice when they are unsure of their answer.
This would artificially increase their measured threshold as a result.

Future Directions
In the future, the present study should be replicated with an added focus on recruiting
more and more varied participants for olfactory and blood analyses. The fluctuations in NPY and
cortisol due to resilience and stress respectively may not be evident when levels of stress are only
mild/moderate. The results can be confirmed along the entire range of scores by specifically
targeting individuals who score very high on depression, traumatic stress, and stress. This will
enhance the generalizability of the study to cover people with all levels of stress and depression.
Additional work needs to be done with other odorants as well. Future experiments should
incorporate compounds that bind with OBPs as well as those that do not. This will help to
elucidate the specific interactions that underlie how mood may affect olfactory ability. Aside
from this dichotomy, there are also odorants with middling affinity for OBPs (Pevsner et al.,
1990). These should be tested as well to assess the properties of stress and olfaction over the
whole range of binding activity.
In regard to taking blood samples for physiological measures, there are a number of steps
that should be taken in future studies to ensure the utility of such analyses. In addition to cortisol
and NPY, serotonin could also be quantified as the marker for depression (Tamatam, Khanum, &
Bawa, 2012). To correct for the variance in concentrations of these compounds (both within and
between subjects), participants would need to give blood multiple times throughout a given test
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day. Their eating habits would also need to be strictly regulated to control for the fluctuations in
NPY due to hunger. Finally, assessing heart rate would also be prudent for ensuring accurate
measurements; a change in heart rate immediately before giving blood (due to arousal from
seeing the needle, for example) would indicate a likely increase in cortisol level that is not
otherwise related to the target variables of the current study.
Ultimately, the current study joins the previous literature in suggesting a link between
stress and the sense of smell, even when stress is rated as mild to moderate. The mechanism
behind this interaction, however, has still not been definitively confirmed. This therefore should
be the primary goal in future research into olfaction and psychological well-being. As the
relationship between the two becomes better comprehended, the focus of study should broaden to
incorporate the diagnostic capabilities of this knowledge. Given that the threshold and response
bias for p-cresol were predictive of general stress levels, it is exciting to consider extending the
utility of measuring olfactory ability towards diagnostic purposes. Specifically within the
purview of the current study, the theorized relationship between olfactory performance and
traumatic stress could aid in the diagnosis of PTSD. This disorder is uniquely difficult to
adequately diagnose due to the wide array of symptoms and causes that may present (Rosen,
Spitzer, & McHugh, 2008). Having a reliable, noninvasive diagnostic measure that includes a
measure of response bias would therefore be highly beneficial for practitioners. This study
provides strong evidence for a relationship among stress, resilience, and olfaction, which should
help guide future research into the intersection of psychology and olfaction.
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University of Tennessee at Chattanooga Research Study:
Odor Sensitivity and Blood Protein Levels (Phase I)
SUBJECT INFORMATION AND CONSENT FORM
Your participation in this research study is strictly voluntary, meaning that you may or may not choose to
take part.
The purpose of the study is to determine whether the sense of smell may be tied to stress through the
action of certain blood-borne proteins. Once you have provided your consent to participate in the study,
information about you and your health history will be collected and you will be given a self-report
survey to complete. This constitutes phase I of the study; if you are interested in taking part in Phase II
you can give your contact information to us following the survey.
POTENTIAL BENEFITS: There is no guarantee of personal benefit as a result of your participation. Your
participation in this study may provide information that may help people with anosmia (loss of taste and
smell) and people suffering from depression or stress disorders.
COSTS TO YOU: There is no cost to you for participation in this study.
COMPENSATION TO YOU: You will receive no tangible compensation from the investigators for your
participation in Phase I of this study. Completion of Phase I does qualify you for Phase II, in which $10
gift certificates are given as compensation.
WITHDRAWAL AND TERMINATION: Your participation in this study is completely voluntary. You may
decide not to participate or you may leave the study at any time. Your decision will not result in any
penalty or loss of benefits.
CONFIDENTIALITY: As a part of this research, we will collect and use records that contain information or
data about you and your health. Under the privacy laws, you have the right to decide who can use your
personal health information (called PHI). When you sign this consent form, you are agreeing that you
will allow the use or your personal health information for this study. The information that will be
collected about you as a part of this research includes: Name, Birth date, race, allergies, medications,
etc., Information collected about you for the study will be kept in a research file that is separate from
your medical chart and all information about you will be kept confidential. You will not be able to see
your research file until after the end of the study.
AUTHORIZATION FOR USE AND DISCLOSURE OF PROTECTED HEALTH INFORMATION FOR RESEARCH
PURPOSES: You have agreed to participate in a research study that has been described to you in the
research consent form above. To do this research, we need to collect health information that identifies
you. There is a federal law called the Health Insurance Portability and Accountability Act of 1996
(HIPAA). This law protects the confidentiality of your protected health information. Protected health
information is information about you that could be used to find out who you are.
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HOW WILL MY INFORMATION BE USED? The researchers may use your health information to analyze
and evaluate the results of the study. Study data does not directly identify you. The study may be
published in psychology journals or may be shared with others as part of scientific discussions. Your
name will not be included in any summary of this study.
WHO CAN SEE YOUR RECORDS? By signing this consent form, you are letting the researchers at the
University Of Tennessee at Chattanooga and the Southeast Renal Research Institute see your PHI
collected in this study. All Personal Information and Health Information will be kept confidential.
PATIENT CONSENT: I hereby freely and voluntarily consent to participate in the study described above.
This consent is given based on the verbal and written information provided to me, and the
understanding that I am medically and physically qualified to participate in this study. I am free to ask
questions at any time. I understand I have the option to choose not to participate or to withdraw from
the study at any time without incurring any penalty or loss of benefits otherwise available to me. I
understand that by consenting to participate in this study, I am responsible for carrying out instructions
and that I must relate to the study personnel any information that might be pertinent to the study, such
as side effects of the treatment or procedure. I understand that any significant new findings or
discoveries during the course of this research which may be related to my willingness to continue
participation will be provided to me. I have read, or have had read to me, the above statements, and
understand them as they apply to me. I further understand that I may revoke this consent at any time,
except to the extent that action has already been taken in accord with this consent. I have been told
that, if I have additional questions about the study, I may contact William Heaton (principal investigator
for this study; hxw451@mocs.utc.edu) or I. N. Ozbek, Ph.D., Professor of Psychology at UTC; nickyozbek@utc.edu, either of whom can be contacted through the UTC Psychology office at 423-425-4262.

________________________________________
Printed name of participant

________________________________________

______________________

Signature of participant

Date/Time

_______________________________________

_______________________

Research Assistant Obtaining Consent

Date/Time
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University of Tennessee at Chattanooga Research Study:
Odor Sensitivity and Blood Protein Levels (Phase II)
SUBJECT INFORMATION AND CONSENT FORM
Your participation in this research study is strictly voluntary, meaning that you may or may not choose to
take part.
The purpose of the study is to determine whether the sense of smell may be tied to stress through the
action of certain blood-borne proteins. This phase requires your presence at Blood Assurance of
Chattanooga. Once you have provided your consent to participate in the study, you will take a smell test
that involves smelling a series of vials. Following this test, you will give a small amount of blood (taken
by professional phlebotomists at Blood Assurance) that will be analyzed for certain protein levels. You
will also be given the option to donate blood to Blood Assurance at that time.
POTENTIAL BENEFITS: There is no guarantee of personal benefit as a result of your participation. Your
participation in this study may provide information that may help people with anosmia (loss of taste and
smell) and people suffering from depression or stress disorders.
COSTS TO YOU: There is no cost to you for participation in this study.
COMPENSATION TO YOU: Participants who complete Phase II of the study will receive a $10 gift card.
For your information, the Internal Revenue Service (IRS) has ruled that a research participant can ‘earn’
up to $600.00 a year as a participant in research studies, before monies (gift cards) are considered
income and subject to tax.
WITHDRAWAL AND TERMINATION: Your participation in this study is completely voluntary. You may
decide not to participate or you may leave the study at any time. Your decision will not result in any
penalty or loss of benefits.
CONFIDENTIALITY: As a part of this research, we will collect and use records that contain information or
data about you and your health. Under the privacy laws, you have the right to decide who can use your
personal health information (called PHI). When you sign this consent form, you are agreeing that you
will allow the use or your personal health information for this study. The information that will be
collected about you as a part of this research includes: Name, Birth date, race, allergies, medications,
etc., Information collected about you for the study will be kept in a research file that is separate from
your medical chart and all information about you will be kept confidential. You will not be able to see
your research file until after the end of the study.
AUTHORIZATION FOR USE AND DISCLOSURE OF PROTECTED HEALTH INFORMATION FOR RESEARCH
PURPOSES: You have agreed to participate in a research study that has been described to you in the
research consent form above. To do this research, we need to collect health information that identifies
you. There is a federal law called the Health Insurance Portability and Accountability Act of 1996
(HIPAA). This law protects the confidentiality of your protected health information. Protected health
information is information about you that could be used to find out who you are.
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HOW WILL MY INFORMATION BE USED? The researchers may use your health information to analyze
and evaluate the results of the study. Study data does not directly identify you. The study may be
published in psychology journals or may be shared with others as part of scientific discussions. Your
name will not be included in any summary of this study.
WHO CAN SEE YOUR RECORDS? By signing this consent form, you are letting the researchers at the
University Of Tennessee at Chattanooga and the Southeast Renal Research Institute see your PHI
collected in this study. All Personal Information and Health Information will be kept confidential.
PATIENT CONSENT: I hereby freely and voluntarily consent to participate in the study described above.
This consent is given based on the verbal and written information provided to me, and the
understanding that I am medically and physically qualified to participate in this study. I am free to ask
questions at any time. I understand I have the option to choose not to participate or to withdraw from
the study at any time without incurring any penalty or loss of benefits otherwise available to me. I
understand that by consenting to participate in this study, I am responsible for carrying out instructions
and that I must relate to the study personnel any information that might be pertinent to the study, such
as side effects of the treatment or procedure. I understand that any significant new findings or
discoveries during the course of this research which may be related to my willingness to continue
participation will be provided to me. I have read, or have had read to me, the above statements, and
understand them as they apply to me. I further understand that I may revoke this consent at any time,
except to the extent that action has already been taken in accord with this consent. I have been told
that, if I have additional questions about the study, I may contact William Heaton (principal investigator
for this study; hxw451@mocs.utc.edu) or I. N. Ozbek, Ph.D., Professor of Psychology at UTC; nickyozbek@utc.edu, either of whom can be contacted through the UTC Psychology office at 423-425-4262.

________________________________________
Printed name of participant

________________________________________

______________________

Signature of participant

Date/Time

_______________________________________

_______________________

Research Assistant Obtaining Consent

Date/Time
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Appendix F
CENTER FOR EPIDEMIOLOIGCAL STUDIES DEPRESSION SCALE REVISED (CESD-R)
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58

PTSD Checklist-Civilian Form (PCL-C)
Below is a list of problems and complaints that people sometimes have in response to stressful life experiences.
Please read each one carefully, and then fill in the circle of the response to indicate how much you have been
bothered by that problem IN THE PAST MONTH. Please fill in ONE option only for each question.

Response
1.

Repeated, disturbing memories, thoughts, or images of a stressful
experience from the past?

2.

Repeated, disturbing dreams of a stressful experience from the
past?

3.

Suddenly acting or feeling as if a stressful experience were
happening again (as if you were reliving it)?

4.

Feeling very upset when something reminded you of a stressful
experience from the past?

5.

Having physical reactions (e.g., heart pounding, trouble breathing,
or sweating) when something reminded you of a stressful
experience from the past?

6.

Avoid thinking about or talking about a stressful experience from
the past or avoid having feelings related to it?

7.

Avoid activities or situations because they remind you of a stressful
experience from the past?

8.

Trouble remembering important parts of a stressful experience
from the past?

9.
10.
11.

Loss of interest in things that you used to enjoy?
Feeling distant or cut off from other people?
Feeling emotionally numb or being unable to have loving feelings
for those close to you?

12.
13.
14.
15.
16.
17.

Feeling as if your future will somehow be cut short?
Trouble falling or staying asleep?
Feeling irritable or having angry outbursts?
Having difficulty concentrating?
Being “super alert” or watchful on guard?
Feeling jumpy or easily startled?
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Not at

A little

Moderately

Quite a

Extremely

all (1)

bit (2)

(3)

bit (4)

(5)

Appendix H
HPLC INSTRUMENT SETTINGS
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